천식 치료제 시장 : 약품 유형별, 제품 유형별, 투여 경로별, 국가별, 지역별: 산업 분석, 시장 규모, 시장 점유율 및 예측(2023-2030년)

REPORT HIGHLIGHT

Asthma Therapeutics Market size was valued at USD 24,100 Million in 2022, expanding at a CAGR of 5.1% from 2023 to 2030.

Asthma therapeutics encompass a spectrum of medicines and interventions devised to manage and relieve the symptoms of asthma, a persistent respiratory condition marked by airway inflammation and increased responsiveness. These therapies aim to regulate manifestations like wheezing, breath shortness, chest constriction, and coughing. They fall into two primary categories: long-term control drugs that aim to prevent symptoms and diminish airway inflammation, and quick-relief or rescue medications for immediate relief during asthma attacks. Long-term control medications commonly involve inhaled corticosteroids, long-acting beta-agonists, leukotriene modifiers, and biologics, while short-acting beta-agonists and anticholinergics are typically used as rescue drugs. Additionally, treatment plans may incorporate tailored approaches, lifestyle adjustments, and educational programs on managing asthma to enhance individuals' control and enhance their quality of life while reducing the risk of asthma flare-ups. Consistent monitoring and adjustment of treatment by healthcare professionals are crucial for effective asthma care.

Asthma Therapeutics Market- Market Dynamics

Surge in respiratory illnesses alongside the demand for cost-efficient treatment options to propel market demand

The surge in respiratory illnesses alongside the demand for cost-efficient treatment options underlies the significance of asthma therapeutics. According to the World Health Organization's (WHO) May 2023 report, approximately 262 million people were affected by asthma in 2019, resulting in 455,000 global deaths. Factors such as increasing indoor and outdoor triggers like pollution, allergens, dust, and evolving lifestyles are anticipated to drive growth in the asthma therapeutics sector. Furthermore, heightened awareness and education about asthma among patients, caregivers, and medical practitioners are likely to augment treatments. Events like the World Congress of Asthma, held annually to disseminate knowledge and advancements among experts, aid in comprehending the disease and advancing treatment options. Investments in research and development (R&D) for novel drugs and devices catering to asthma patients, such as biologics, biosimilars, inhalers, nebulizers, and smart devices, are expected to enhance asthma management and promote market expansion. Notably, BiosanaPharma completed phase 1 clinical trials for a biosimilar to omalizumab, an FDA-approved drug for asthma and chronic idiopathic urticaria. Such breakthroughs are pivotal in enhancing patient access to treatment options.

Asthma Therapeutics Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.1% over the forecast period (2023-2030)

Based on Drug Class segmentation, combination therapy was predicted to show maximum market share in the year 2022

Based on Product Type segmentation, inhaled was the leading type in 2022

On the basis of region, North America was the leading revenue generator in 2022

Asthma Therapeutics Market- Segmentation Analysis:

The Global Asthma Therapeutics Market is segmented on the basis of Drug Class, Product Type, Route of Administrations, and Region.

The market is divided into three categories based on Drug Class: combination therapy, anti-inflammatory drugs, and bronchodilators. In 2022, the combination therapy segment, notably the combination of inhaled corticosteroids with long-acting beta-agonists, held the primary market share within the therapeutic class. This class is acclaimed for its amplified therapeutic effects, widespread availability, and improved patient adherence to medication.

The market is divided into three categories based on route of administration: oral, inhaled, and other methods. In 2022, the inhaled drugs segment claimed the largest revenue share due to the higher adoption rates and improved patient compliance with pulmonary drug delivery systems in asthma treatment strategies. The escalating awareness among patients regarding alternative asthma therapies and the simplicity associated with these advanced drug delivery systems are driving the growth of this segment over the projected period.

Asthma Therapeutics Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Asthma Therapeutics Market- Competitive Landscape:

Companies specializing in asthma therapeutics in the pharmaceutical and healthcare sectors employ diverse strategies to enhance their offerings. Their focus remains steadfast on continuous research and development (R&D) to innovate and introduce new medications, formulations, and delivery systems. This involves creating novel drugs targeting specific inflammatory pathways or introducing advanced inhaler technologies for more effective drug administration. Companies prioritize conducting clinical trials and evidence-based studies to showcase the efficacy and safety of their asthma medications. Obtaining regulatory approvals and complying with rigorous standards are critical for market penetration and acceptance. Moreover, there is a burgeoning emphasis on personalized medicine approaches, intending to customize treatments based on individual patient characteristics, genetics, and responses to therapies. This includes delving into biomarkers and predictive analytics to identify patient subgroups that may benefit more from specific medications or therapies. Furthermore, marketing strategies center on educating healthcare providers and patients about the latest advancements in asthma management, emphasizing the importance of adhering to treatment plans and increasing awareness about available options. Additionally, companies actively engage in collaborations and partnerships, collaborating with research institutions, advocacy groups, and healthcare organizations to drive innovation, enhance patient care, and broaden their market presence. Key industry players are implementing various business strategies to fortify their positions, including new product launches, obtaining approvals, and engaging in acquisitions and mergers.

Recent Developments:

In February 2022, Mankind Pharma revealed an agreement with Dr. Reddy's Laboratories Ltd. to obtain Combihale and Daffy. Combihale, an inhaler brand used for treating asthma and COPD, was valued at USD 109 million with a growth rate of 14%. This strategic move is anticipated to bolster the company's product portfolio and confer a competitive advantage against its rivals.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ASTHMA THERAPEUTICS MARKET KEY PLAYERS

• Teva Pharmaceutical Industries Ltd.
• GSK plc.
• Merck& Co., Inc.
• F. Hoffmann-La Roche Ltd
• AstraZeneca
• Boehringer Ingelheim International GmbH.
• Sanofi
• Koninklijke Philips N.V.
• BD
• Sunovion Pharmaceuticals, Inc.
• Others

GLOBAL ASTHMA THERAPEUTICS MARKET, BY DRUG CLASS

• Anti-inflammatory
• Bronchodilators
• Combination Therapy

GLOBAL ASTHMA THERAPEUTICS MARKET, BY PRODUCT TYPE

• Inhaler
• Nebulizers

GLOBAL ASTHMA THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATIONS

• Oral
• Inhaled
• Others

GLOBAL ASTHMA THERAPEUTICS MARKET, BY REGION

• North America
• The U.S.
• Canada
• Europe
• Germany
• France
• Italy
• Spain
• United Kingdom
• Russia
• Netherlands
• Sweden
• Poland
• Rest of Europe
• Asia Pacific
• India
• China
• South Korea
• Japan
• Australia
• Thailand
• Indonesia
• Philippines
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM
• The Middle East and Africa
• Saudi Arabia
• United Arab Emirates
• Israel
• Turkey
• Algeria
• Egypt
• Rest of MEA

Table of Contents

1. Asthma Therapeutics Market Overview

• 1.1. Study Scope
• 1.2. Market Estimation Years

2. Executive Summary

• 2.1. Market Snippet
  • 2.1.1. Asthma Therapeutics Market Snippet by Drug Class
  • 2.1.2. Asthma Therapeutics Market Snippet by Product Type
  • 2.1.3. Asthma Therapeutics Market Snippet by Route of Administration
  • 2.1.4. Asthma Therapeutics Market Snippet by Country
  • 2.1.5. Asthma Therapeutics Market Snippet by Region
• 2.2. Competitive Insights

3. Asthma Therapeutics Key Market Trends

• 3.1. Asthma Therapeutics Market Drivers
  • 3.1.1. Impact Analysis of Market Drivers
• 3.2. Asthma Therapeutics Market Restraints
  • 3.2.1. Impact Analysis of Market Restraints
• 3.3. Asthma Therapeutics Market Opportunities
• 3.4. Asthma Therapeutics Market Future Trends

4. Asthma Therapeutics Industry Study

• 4.1. PEST Analysis
• 4.2. Porter's Five Forces Analysis
• 4.3. Growth Prospect Mapping
• 4.4. Regulatory Framework Analysis

5. Asthma Therapeutics Market: COVID-19 Impact Analysis

• 5.1. Pre-COVID-19 Impact Analysis
• 5.2. Post-COVID-19 Impact Analysis
  • 5.2.1. Top Performing Segments
  • 5.2.2. Marginal Growth Segments
  • 5.2.3. Top Looser Segments
  • 5.2.4. Marginal Loss Segments

6. Asthma Therapeutics Market Landscape

• 6.1. Asthma Therapeutics Market Share Analysis, 2022
• 6.2. Breakdown Data, by Key Manufacturer
  • 6.2.1. Established Players' Analysis
  • 6.2.2. Emerging Players' Analysis

7. Asthma Therapeutics Market - By Drug Class

• 7.1. Overview
  • 7.1.1. Segment Share Analysis, By Drug Class, 2022 & 2030 (%)
  • 7.1.2. Anti-inflammatory
  • 7.1.3. Bronchodilators
  • 7.1.4. Combination Therapy

8. Asthma Therapeutics Market - By Product Type

• 8.1. Overview
  • 8.1.1. Segment Share Analysis, By Product Type, 2022 & 2030 (%)
  • 8.1.2. Inhaler
  • 8.1.3. Nebulizers

9. Asthma Therapeutics Market - By Route of Administration

• 9.1. Overview
  • 9.1.1. Segment Share Analysis, By Route of Administration, 2022 & 2030 (%)
  • 9.1.2. Oral
  • 9.1.3. Inhaled
  • 9.1.4. Others

10. Asthma Therapeutics Market- By Geography

• 10.1. Introduction
  • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
• 10.2. North America
  • 10.2.1. Overview
  • 10.2.2. Asthma Therapeutics Key Manufacturers in North America
  • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 10.2.4. North America Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
  • 10.2.5. North America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  • 10.2.6. North America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.2.7. U.S.
    • 10.2.7.1. Overview
    • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.2.7.3. U.S. Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.2.7.4. U.S. Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.2.7.5. U.S. Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.2.8. Canada
    • 10.2.8.1. Overview
    • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.2.8.3. Canada Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.2.8.4. Canada Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.2.8.5. Canada Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
• 10.3. Europe
  • 10.3.1. Overview
  • 10.3.2. Asthma Therapeutics Key Manufacturers in Europe
  • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 10.3.4. Europe Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
  • 10.3.5. Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  • 10.3.6. Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.3.7. Germany
    • 10.3.7.1. Overview
    • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.7.3. Germany Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.3.7.4. Germany Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.3.7.5. Germany Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.3.8. Italy
    • 10.3.8.1. Overview
    • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.8.3. Italy Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.3.8.4. Italy Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.3.8.5. Italy Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.3.9. United Kingdom
    • 10.3.9.1. Overview
    • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.9.3. United Kingdom Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.3.9.4. United Kingdom Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.3.9.5. United Kingdom Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.3.10. France
    • 10.3.10.1. Overview
    • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.10.3. France Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.3.10.4. France Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.3.10.5. France Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.3.11. Russia
    • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.11.2. Russia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.3.11.3. Russia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.3.11.4. Russia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.3.12. Netherlands
    • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.12.2. Netherlands Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.3.12.3. Netherlands Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.3.12.4. Netherlands Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.3.13. Sweden
    • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.13.2. Sweden Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.3.13.3. Sweden Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.3.13.4. Sweden Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.3.14. Poland
    • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.14.2. Poland Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.3.14.3. Poland Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.3.14.4. Poland Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.3.15. Rest of Europe
    • 10.3.15.1. Overview
    • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
• 10.4. Asia Pacific (APAC)
  • 10.4.1. Overview
  • 10.4.2. Asthma Therapeutics Key Manufacturers in Asia Pacific
  • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 10.4.4. Asia Pacific Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
  • 10.4.5. Asia Pacific Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  • 10.4.6. Asia Pacific Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.4.7. India
    • 10.4.7.1. Overview
    • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.7.3. India Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.4.7.4. India Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.4.7.5. India Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.4.8. China
    • 10.4.8.1. Overview
    • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.8.3. China Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.4.8.4. China Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.4.8.5. China Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.4.9. Japan
    • 10.4.9.1. Overview
    • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.9.3. Japan Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.4.9.4. Japan Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.4.9.5. Japan Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.4.10. South Korea
    • 10.4.10.1. Overview
    • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.10.3. South Korea Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.4.10.4. South Korea Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.4.10.5. South Korea Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.4.11. Australia
    • 10.4.11.1. Overview
    • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.11.3. Australia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.4.11.4. Australia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.4.11.5. Australia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.4.12. Thailand
    • 10.4.12.1. Overview
    • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.12.3. Thailand Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.4.12.4. Thailand Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.4.12.5. Thailand Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.4.13. Indonesia
    • 10.4.13.1. Overview
    • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.13.3. Indonesia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.4.13.4. Indonesia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.4.13.5. Indonesia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.4.14. Philippines
    • 10.4.14.1. Overview
    • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.14.3. Philippines Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.4.14.4. Philippines Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.4.14.5. Philippines Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.4.15. Rest of APAC
    • 10.4.15.1. Overview
    • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.15.3. Rest of APAC Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.4.15.4. Rest of APAC Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.4.15.5. Rest of APAC Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
• 10.5. Latin America
  • 10.5.1. Overview
  • 10.5.2. Asthma Therapeutics Key Manufacturers in Latin America
  • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 10.5.4. Latin America Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
  • 10.5.5. Latin America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  • 10.5.6. Latin America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.5.7. Brazil
    • 10.5.7.1. Overview
    • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.5.7.3. Brazil Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.5.7.4. Brazil Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.5.7.5. Brazil Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.5.8. Mexico
    • 10.5.8.1. Overview
    • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.5.8.3. Mexico Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.5.8.4. Mexico Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.5.8.5. Mexico Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.5.9. Argentina
    • 10.5.9.1. Overview
    • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.5.9.3. Argentina Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.5.9.4. Argentina Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.5.9.5. Argentina Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.5.10. Colombia
    • 10.5.10.1. Overview
    • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.5.10.3. Colombia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.5.10.4. Colombia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.5.10.5. Colombia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.5.11. Rest of LATAM
    • 10.5.11.1. Overview
    • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
• 10.6. Middle East and Africa
  • 10.6.1. Overview
  • 10.6.2. Asthma Therapeutics Key Manufacturers in Middle East and Africa
  • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 10.6.4. Middle East and Africa Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
  • 10.6.5. Middle East and Africa Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  • 10.6.6. Middle East and Africa Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.6.7. Saudi Arabia
    • 10.6.7.1. Overview
    • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.6.8. United Arab Emirates
    • 10.6.8.1. Overview
    • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.6.9. Israel
    • 10.6.9.1. Overview
    • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.9.3. Israel Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.6.9.4. Israel Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.6.9.5. Israel Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.6.10. Turkey
    • 10.6.10.1. Overview
    • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.10.3. Turkey Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.6.10.4. Turkey Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.6.10.5. Turkey Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.6.11. Algeria
    • 10.6.11.1. Overview
    • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.11.3. Algeria Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.6.11.4. Algeria Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.6.11.5. Algeria Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.6.12. Egypt
    • 10.6.12.1. Overview
    • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.12.3. Egypt Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.6.12.4. Egypt Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.6.12.5. Egypt Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.6.13. Rest of MEA
    • 10.6.13.1. Overview
    • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.13.3. Rest of MEA Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.6.13.4. Rest of MEA Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.6.13.5. Rest of MEA Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Asthma Therapeutics Industry

• 11.1. Competitive Dashboard
• 11.2. Company Profiles
  • 11.2.1. Teva Pharmaceutical Industries Ltd.
  • 11.2.2. GSK plc.
  • 11.2.3. Merck& Co., Inc.
  • 11.2.4. F. Hoffmann-La Roche Ltd
  • 11.2.5. AstraZeneca
  • 11.2.6. Boehringer Ingelheim International GmbH.
  • 11.2.7. Sanofi
  • 11.2.8. Koninklijke Philips N.V.
  • 11.2.9. BD
  • 11.2.10. Sunovion Pharmaceuticals, Inc.
  • 11.2.11. Others

12. 360 Degree Analyst View

13. Appendix

• 13.1. Research Methodology
• 13.2. References
• 13.3. Abbreviations
• 13.4. Disclaimer
• 13.5. Contact Us